HCAR2 agonist 1 is a Gi protein-biased allosteric modulator of HCAR2 that activates Gi protein signaling pathways; it exhibits anti-inflammatory effects by reducing mRNA levels of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, and MCP-1) and enhances the anti-inflammatory efficacy of orthosteric agonists in a murine colitis model.